Glenmark gets regulator’s approval to try Favipiravir on COVID-19 patients in India
MUMBAI: Glenmark Pharmaceuticals, a research-led pharmaceutical company, announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India...